Common use of Rights to Data Clause in Contracts

Rights to Data. Any data generated by ADCT using the Licensed Intellectual Property in conceiving and/or reducing to practice a PBD conjugated to a targeting agent shall be provided to MedImmune and may be used by MedImmune in prosecuting its own intellectual property and/or for general business purposes; provided that (a) such data must be “anonymized” as reasonably required by ADCT for confidentiality purposes; and (b) any use of such “anonymized” data shall be subject to the obligations to have such use reviewed as provided in Section 5.2 below (even if the use is not a publication or disclosure as described in such section, but such Section 5.2 shall also apply to any use by MedImmune in connection with prosecuting MedImmune’s own intellectual property).